8-K: Current report filing
Published on May 11, 2004
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (date of earliest event reported): May 11, 2004
COMMONWEALTH BIOTECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
| Virginia | 001-13467 | 56-1641133 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
601 Biotech Drive
Richmond, Virginia 23235
(Address of principal executive offices)
Registrants telephone number, including area code: (804) 648-3820
| ITEM 5. | OTHER EVENTS AND REGULATION FD DISCLOSURE. |
On May 11, 2004, the registrant issued a press release relating to the receipt of new contract awards from government sponsors. A copy of the press release is attached as an exhibit hereto.
| ITEM 7. | FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS. |
| (a) | Financial statements of businesses acquired. |
Not Applicable.
| (b) | Pro forma financial information. |
Not Applicable.
| (c) | Exhibits. |
| 99.1 Press release, dated May 11, 2004, relating to the receipt of new contract awards. |
2
Pursuant to the requirement of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| COMMONWEALTH BIOTECHNOLOGIES, INC. | ||
| By: | /s/ Robert B. Harris, Ph.D. | |
| Robert B. Harris, Ph.D. President and Chief Executive Officer |
||
Dated: May 11, 2004
3
EXHIBIT INDEX
|
Number |
Description of Exhibit |
|
| 99.1 | Press release, dated May 11, 2004, relating to the receipt of new contract awards. |
4